Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
06/08/2026 13:01
BRIEF-Prime Medicine, Inc. Q2 EPS USD -0.24 Aug 06 (Reuters) - Prime Medicine, Inc. Q2 operating expenses USD 44.439 million.
- Q2 net income USD -42.109 million
- Q2 income from operations USD -43.285 million
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease